Mind Medicine Mindmed Inc (NQ: MNMD )
6.020
+0.045
(+0.75%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
All News about Mind Medicine Mindmed Inc
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_134.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/16/image28.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_133.png?width=1200&height=800&fit=crop)
![](https://eresearch.com/wp-content/uploads/2022/05/psychedelic-stocks-1600x630-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8354.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/12/psychedelic_chemistry_olia_danilevich_by_pexels.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_132.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_131.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/08/11/alvaro-serrano-hjwkmkehbco-unsplash.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_130.png?width=1200&height=800&fit=crop)
Toronto Addiction Center Gets First-Ever Federal Grant to Study Effects of Magic Mushroom on Depression
August 10, 2022
Topics
Supply Chain
Exposures
Supply Chain
![](https://investorplace.com/wp-content/uploads/2020/05/psychedelics-3.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_129.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_128.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/08/05/stocks_psychedelics_2_pexels_-_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_127.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_125.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_124.png?width=1200&height=800&fit=crop)
![](https://eresearch.com/wp-content/uploads/2022/05/psychedelic-stocks-1600x630-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_123.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_122.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_121.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_120.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_119.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_118.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_117.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2020/05/psychedelics-3.jpg)
![](https://investorplace.com/wp-content/uploads/2020/07/biopharma-1600.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/psychedelic_image_116.png?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.